Ghorbat ALİ, Malika NAJEEB, Amad JUBRAİL, ZELİHA SELAMOĞLU

A Study of Vitamin D and Calcium Level in Beta Thalassemia Major in Duhok Province

β-thalassemia major is severe hemolytic anemia which requires repeated blood transfusion and for survival, which leading to iron overload. Serious complications due to iron over load are recognized in the thalassemia patients. objectives Vitamin D and calcium are important factors for homeostasis of calcium in this study. This study was conducted for a period of two year including from patients with β- thalassemia major from Duhok Thalassemia Centre between 2014 -2015. Thirty eighth βthalassemia major patients and thirty eighth persons with age- matched as control group were enrolled in the study. Serum concentration of 25- hydroxy vitamin D and calcium were estimated by enzyme linked fluorescent assay and colorimetric method, respectively. In patients, the level of serum 25- hydroxy vitamin D was significantly lower 11.11±4.36 ng/mL compared with control group (14.03±5.96ng/mL). Vitamin D deficiency is observed about 94.73% in patients. The mean level of serum calcium in patients group is 7.9±0.47mg/dL and 8.98±0.77 mg/dL in control group. There was a statistically significant difference in serum calcium value between patients and control group. 44.73% of patients have hypocalcaemia. This study demonstrated a high prevalence of Vitamin D deficiency and low total serum calcium levels in thalassemia patients with a significantly lower than healthy group. Hypocalcemia and vitamin D deficiency may be results from the negative effect of the repeated blood transfusion and malnourishment.

PDF

___

Agrawal A, Garg M, Singh J, Mathur P, Khan K. 2016. A comparative study of 25 hydroxy vitamin D levels in patients of thalassemia and healthy children. Pediatric Review: International Journal of Pediatric Research. 3(9): 652-656.

Al-Muhammadi MO. 2014. Changes in serum iron, total iron binding capacity, calcium and phosphorus concentrations in children with beta thalassemia major in Babylon Governorate. Kufa Med. Journal. 14(1): 253-261.

Al-Samarrai AH, Adaay MH, Al-Tikriti KA, Al-Anzy MM. 2008. Evaluation of some essential element levels in thalassemia major patients in Mosul district, Iraq. Saudi Medical Journal. 29(1): 94-97.

Al-Wtaify ASM and Al-Shujairi GSH. 2009. Prevalence of Diabetes and Hypocalcemia among Thalassemic Patients in Thalassemia Center in Babyl on Governorate. Medical Journal of Babylon. 6 (3-4): 672-679.

Barton JC. 2007. Chelation therapy for iron overload. Curr. Gastroenterol. ReP. 9: 74-82.

Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. 2005. LPIlabile plasma iron in iron overload. Best Prat Res Clin Haematol. 18: 277–87.

Casey CF, Slawson DC, Neal LR. 2010. Vitamin D Supplementation in Infants, Children, and Adolescents. Am Fam Physician. 81(6): 745-748.

Cooper MS and Gittoes NJ. 2008. Diagnosis and management of hypocalcaemia. BMJ. 336(7656): 1298–302.

Dandona P, Menon RK, Houlder S, Thomas M, Hoffbrand AV, Flynn DM. 1987. Serum 1,25dihydroxyvitamin D and osteocalcin concentrations in thalassemia major. Archives of disease in childhood. 62(5): 474-7

Danjou F, Anni F, Galanello R. 2011. Beta-thalassemia: from genotype to phenotype. Haematologica. 96(11): 1573–1575.

Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. 2000. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol. 111: 902-907.

Ezzat HM, John Wu J, McCartney H, Leitch HA. 2015. Vitamin D Insufficiency and Liver Iron Concentration in Transfusion Dependent Hemoglobinopathies in British Columbia. Open Journal of Hematology. 6-6 DOI: 10.13055/ojhmt_6_1_6.150608

Fahim FM, Saad K, Askar EA, Eldin EN, Thabet AF. 2013. Growth parameters and vitamin D status in children with thalassemia major in upper Egypt. Int J HematolOncol Stem Cell Res. 7(4): 10–14.

Fung E, Aguilar C, Micaily I, Haines D, Lal A. 2011. Treatment of vitamin D deficiency in transfusion-dependent thalassemia. Am J Hematol. 86: 871–3.

Fung EB1, Xu Y, Trachtenberg F, Odame I, Kwiatkowski JL, Neufeld EJ, Thompson AA, Boudreaux J, Quinn CT, Vichinsky EP. 2012. Inadequate dietary intake in patients with thalassemia. J Acad Nutr Diet. 112(7): 980-90.

Gallo L, Faniello MC, Canino G, Tripolino C, Gnasso A, Cuda G, Costanzo FS, Irace C. 2016. Serum Calcium Increase Correlates with Worsening of Lipid Profile: An Observational Study on a Large Cohort from South Italy. Medicine (Baltimore). 95(8): e2774

Al-Horani H, Abu Dayyih W, Mallah E, Hamad M, Mima M, Awad R, Arafat T. 2016. Nationality, gender, age, and body mass index influences on vitamin D concentration among elderly patients and young Iraqi and Jordanian in Jordan. Biochemistry Research International. ID 8920503, 8 pages Holick MF. 2007. Vitamin D deficiency. New England Journal of Medicine. 357(3): 266- 81.

Holick MF. 2009. Vitamin D Status: Measurement, Interpretation and Clinical Application. Ann Epidemiol. 19(2): 73–78.

Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G, Ragi‐Eis S, Chandler, J. 2006. The prevalence of vitamin D inadequacy amongst women with osteoporosis: An international epidemiological investigation. J Intern Med. 260: 245–54.

Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L, Sriphrapradang A, Domrongkitchaiporn S, Sirisriro R, Rajatanavin R. 2003. Bone histomorphometry in children and adolescents with βthalassemia disease: iron- associated focal osteomalacia. Journal of Clinical Endocrinology and Metabolism. 88(8):966–3972.

Moulas A, Challa A, Chaliasos N, Lapatsanis PD. 1997. Vitamin D metabolites (25-hydroxyvitamin D, 24,25- dihydroxyvitamin D and 1,25-dihydroxyvitamin D) and osteocalcinin B- thalassaemia. Acta Paediatr. 86: 594–599.

Napoli N, Carmina E, Bucchieri S, Sferrazza C, Rini GB, Di Fede G. 2006. Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone. 38(6): 888-92.

Pirinççioğlu AG, Akpolat V, Köksal O, Haspolat K, Söker M. 2011. Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone. 49(4): 819–823.

Porter J, Viprakasit V. 2014. Iron overload and chelation. In: Cappelini, Cohen A, Porter J, Taher A, Viprakasit V, eds. Guidelines for the management of transfusion dependent thalassemia (TDT). 3rd ed. Cyprus: TIF publication Pages 42- 74.

Schwetz V, Trummer C, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, März W, Aberer F, Lang A, Treiber G, Friedl C, Obermayer-Pietsch B, Pieber TR, Tomaschitz A, Pilz S. 2017. Effects of vitamin D supplementation on bone turnover markers: A randomized controlled trial. Nutrients. 9(5): article no. 432.

Sevindik M. 2018. Heavy metals content and the role of Lepiota cristata as antioxidant in oxidative stress. J Bacteriol Mycol Open Access. 6(4): 237-239.

Sevindik M. 2019. The novel biological tests on various extracts of Cerioporus varius. Fresenius Environmental Bulletin. 28(5): 3713-3717.

Sevindik M, Rasul A, Hussain G, Anwar H, Zahoor MK, Sarfraz I, Kamran KS, Akgul H, Akata I, Selamoglu Z. 2018. Determination of anti-oxidative, anti-microbial activity and heavy metal contents of Leucoagaricus leucothites. Pakistan journal of pharmaceutical sciences. 31(5 (Supplementary)): 2163-2168.

Shah S. 2015. Assessment of serum calcium and phosphorus levels among transfusion -dependent beta thalassemia major patients on chelation therapy. J Postgrad Med Inst. 29(3): 168-71.

Shamsiraz A, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, Hashemi R, Shamshirsaz AA, Aghakhani S, Homayoun H, Larijani B. 2003. Metabolic and endocrinological complications in beta- thalassaemia major: a multicenter study in Tehran. BMC Endocrine Disorder. 3:23-34.

Soliman A, Adel A, Wagdy M, Al Ali M, El Mulla N. 2008. Calcium homeostasis in 40 adolescentswith beta- thalassemia major: a case-control study of the effects of intramuscular injection ofa megadose of cholecalciferol. Pediatric Endocrinology Reviews. 6: 149-54.

Soliman A, De Sanctis V, Yassin M. 2013. Vitamin D Status in Thalassemia Major: An Update, Mediterr J Hematol Infect Dis. 5(1): e2013057

Sultan S, Irfan SM, Ahmed SI. 2016. Biochemical Markers of Bone Turnover in Patients with β-Thalassemia Major: A Single Center Study from Southern Pakistan. Adv Hematol. 2016:5437609. doi: 10.1155/2016/5437609.

Vogiatzi MG, Macklin EA, Trachtenberg FL, Fung EB, Cheung AM, Vichinsky E, Holm IA. 2009. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. British Journal of Haematology. 146: 546-56.

Wintermeyer E, Ihle C, Ehnert S, Stöckle U, Ochs G, de Zwart P, Flesch I, Bahrs S, Nussler AK. 2016. Review Crucial Role of Vitamin D in the Musculoskeletal System. Nutrients. 8: 319.

Zittermann A. 2003. Vitamin D in preventive medicine: are weignoring the evidence? Br J Nutr. 89(5): 552-72.